Advances in the development of Salmonella -based vaccine strategies for protection against Salmonellosis in humans
For context, total global diabetes drug sales (pre-GLP1 boom) were ~$5060B
Safety Screening, Contraindications, and Provider Oversight Both Mochi and iV.im screen for absolute contraindications, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, and severe renal impairment
BPC-157 (short for "Body Protection Compound") is one of the most talked-about peptides in the recovery world
Side effects Most common: nausea, vomiting, diarrhea, constipation, abdominal discomfort, headache, fatigue, injection-site reactions
Some research suggests that taking 30 minutes versus five minutes to eat leads to greater secretion of GLP-1